Document is current
Any future updates will be listed below
-
Authors
Taira, Aurora
Palin, Kimmo
Kuosmanen, Anna
Välimäki, Niko
Kuittinen, Outi
Kuismin, Outi
Kaasinen, Eevi
Rajamäki, Kristiina
Aaltonen, Lauri A.
-
Funding
Funding for this research was provided by:
Academy of Finland (312041, 335823)
University of Helsinki
The Emil Aaltonen foundation
Biomedicum Helsinki-säätiö
Orionin Tutkimussäätiö
Ida Montinin Säätiö
iCAN Digital Precision Cancer Medicine Flagship (320185)
Academy Professorship (319083, 320149)
- License Information
-
More Information
Article History
Received: 7 July 2022
Accepted: 9 December 2022
First Online: 14 January 2023
Declarations
:
: The study has been registered with the EudraCT reference number 2018-000155-41. The samples and patient information were obtained with approval from the ethics committee of the Hospital District of Helsinki and Uusimaa, the Northern Ostrobothnia Hospital District as well as National Supervisory Authority for Welfare and Health. Signed informed consent was obtained from all study participants.
: Signed informed consent for data publication was obtained from all study participants.
: The authors declare that they have no competing interests.
